Pritesh Shah, Chief Growth Officer at NovoCure Ltd (NVCR), sold 382 shares at $12.65 ($5K) on 2023-11-07, disclosed to the SEC on 2023-11-08.
Scheduled sale ($5k) by Chief Growth Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |
| NVCR | SELL | 2023-01-09 | $42K | — | Filing → |